Phenprocoumon: Clinical Trials

6 trials of Phenprocoumon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Phenprocoumon: new trials by email Literature Review of Phenprocoumon trials Research Report on Phenprocoumon

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
CE-mark approved LAA closure devices, Acetylsalicylic acid, Clopidogrel - Atrial Fibrillation
Phase 4CompletedCharite University, Berlin, Germany9122018-02-282025-12-12
Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
Vitamin K antagonist, Apixaban - Atrial Fibrillation
Phase 4CompletedAtrial Fibrillation Network6762014-12-012017-10-20
Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
Rivaroxaban or Marcumar - Atrial Fibrillation or Pulmonary Embolism, Need of Long Term Oral Anticoagulation Therapy (OAT)
Phase 4CompletedRWTH Aachen University1922013-07-012020-10-22
Antithrombotic Triple Therapy in Humans
Dabigatran, Ticagrelor, ASA, Rivaroxaban, Ticagrelor, ASA, Phenprocoumon, Ticagrelor, ASA - Atrial Fibrillation, Acute Coronary Syndrome
Phase 4CompletedMedical University of Vienna602012-10-012014-03-06
Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
Dabigatran, Phenprocoumon - Atrial Fibrillation
Phase 4CompletedDeutsches Herzzentrum Muenchen702011-04-012013-07-02
Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon
Algorithm for phenprocoumon, algorithm for phenprocoumon, Phenprocoumon - Pulmonary Embolism, Atrial Fibrillation
Phase 4CompletedCantonal Hospital of St. Gallen3022007-01-012012-04-02

Conditions studied

Atrial Fibrillation (6)  ·  Pulmonary Embolism (2)  ·  Acute Coronary Syndrome (1)  ·  Stroke (1)

Sponsors

Atrial Fibrillation Network (1)  ·  Cantonal Hospital of St. Gallen (1)  ·  Charite University, Berlin, Germany (1)  ·  Deutsches Herzzentrum Muenchen (1)  ·  Medical University of Vienna (1)  ·  RWTH Aachen University (1)

Countries

Germany (4)  ·  Austria (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Julinda Mehilli, MD (1)  ·  Michael Wolzt, Prof. MD (1)  ·  Paulus Kirchhof, Professor (1)  ·  Samuel Henz, MD MPH (1)  ·  Ulf Landmesser, MD (1)  ·  Wolfgang Korte, MD (1)

Results publications

PMID 23299853, PMID 25211369, PMID 32725107, PMID 35135308, PMID 37897713, PMID 40946883, PMID 41849741, PMID 42459774

NIH funding

2014 (1)